Under terms of the alliance, MID acquires a non-exclusive worldwide license to OSCOR's patented catheter technology and in turn, OSCOR receives exclusive manufacturing rights to MID's MIA devices.
Micro Interventional Devices, Inc.™ (MID) announced today the world's first percutaneous implantation of its MIA™, Minimally Invasive Annuloplasty, technology for tricuspid and mitral repair, which marks the first patient enrolled in the transcatheter arm of the STTAR trial.
Medidata (NASDAQ:MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
HMS, a leading provider of cost containment and health management solutions to the U.S. healthcare market, has launched a strategic partnership with Halfpenny Technologies, to strengthen payer-provider coordination and promote seamless care management.
Tabula Rasa HealthCare was named by Rock Health as the best performing IPO among digital health companies in 2017. Tabula Rasa's stock is up 140% based on YTD growth, which is the largest percent increase among public digital health companies in 2017.
Six biopharma companies have chosen to launch their new therapies using the SHYFT Platform. The number of SHYFT Launch customers has increased 50% year over year propelled by the company’s uniquely integrated cloud-based data companies and analytics solutions.
The investment, led by BlueCross BlueShield Venture Partners, with participation from us, Activate Venture Partners, and Primary Venture Partners will accelerate team growth, enhance new coordination product line, and support national expansion.
Tandigm Health, a value-based healthcare company supporting primary care physicians, has engaged Tabula Rasa Healthcare to assess the medication regimens of high-risk patients who were recently discharged from the hospital.